Dr. Julie Brahmer on the PD-1 Targeted Immunotherapy BMS-93655 Clinical Trial
Автор: OncLive
Загружено: 2012-06-07
Просмотров: 1537
Описание:
Julie R. Brahmer, MD, associate professor of oncology, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Hospital, discusses a phase I clinical trial that investigated the experimental agent BMS-93655, a targeted immunotherapy agent that blocks the programmed death-1 (PD-1) receptor that is expressed by activated T cells, in multiple tumor types.
Find out more, at http://www.onclive.com/onclive-tv/Dr-...
Повторяем попытку...
Доступные форматы для скачивания:
Скачать видео
-
Информация по загрузке: